Zoledronic acid increases spine bone mass and prevents hip bone loss after bariatric surgery: a randomized placebo‐controlled study
Zoledronic acid increases bone mass in the spine and prevents bone loss in the hip region after bariatric surgery compared with placebo.
Authors
- Stinus Hansen (ORCID: https://orcid.org/0000-0001-9486-0316)
- Martin Weber Kusk (ORCID: https://orcid.org/0000-0003-1392-6497)
- Søren Gam (ORCID: https://orcid.org/0000-0002-2461-2824)
- Claus Bogh Juhl (ORCID: https://orcid.org/0000-0002-4285-5459)
- Anne Pernille Hermann (ORCID: https://orcid.org/0000-0001-6701-0981)
- Bibi Gram (ORCID: https://orcid.org/0000-0001-7655-688X)
- Simon Lysdahlgaard
Institutions
- Steno Diabetes Centers (DK)
- University of Southern Denmark (DK)
- Odense University Hospital (DK)
- Hospital South West Jutland (DK)
Publication Details
- Journal
- Obesity
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1002/oby.24214
- Citations
- 4
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 8.03
Funders
- Syddansk Universitet
- Fonden til Lægevidenskabens Fremme